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Summary
Electromagnetic fields arising from magnetic resonance
imaging (MRI) can cause various clinically relevant func-
tional disturbances in patients with cardiac pacemakers.
Consequently, an implanted pacemaker is generally con-
sidered a contraindication for an MRI scan. With approx-
imately 60 million MRI scans performed worldwide per
year, MRI may be indicated for an estimated majority of
pacemaker patients during the lifetime of their pacemakers.
The availability of MR conditional pacemakers with CE la-
belling is of particular advantage since they allow the safe
use of pacemakers in MRI. In this article the current state of
knowledge on pacemakers and MR imaging is discussed.
We present the results of a survey conducted among Swiss
radiologists to assess current practice in patients with pace-
makers.
Key words: magnetic resonance imaging (MRI);
pacemakers; MR conditional pacemakers; survey;
radiologists, contraindication
Introduction
Magnetic resonance imaging (MRI) is currently considered
the imaging method of choice for a wide spectrum of dis-
eases and pathologies. Due to its excellent soft-tissue con-
trast, MRI is useful in particular for imaging of the brain,
the head and neck, the spine and the musculoskeletal sys-
tem. In recent years MRI has also proven useful for the
imaging of other body areas including the abdomen, pelvis,
breast, heart and vascular system. Apart from imaging mor-
phology MRI also provides insights into tissue function
and metabolism. In combination with novel contrast agents
MRI makes it possible to selectively visualise certain cell
lines enabling cell-specific imaging. Another advantage of
MRI is the lack of potentially harmful irradiation. The
number of MRI scans is still increasing annually, and the
trend towards increasing use of MRI will continue in the
future, due to the nearly unlimited potential of the method.
The growing problem
Parallel to the growth and evolution of MR technology an
increasing number of patients are benefiting from cardiac
pacemakers [1–2]. In 2009, 4085 initial implantations of
cardiac pacemakers were recorded in Switzerland. In total,
Original article Swiss Med Wkly. 2011;141:w13147 · www.smw.ch E1
31 825 patients in Switzerland have a pacemaker implanted
and are monitored by cardiologists [3]. With the growing
proportion of the elderly population it can be expected that
the number of pacemaker patients will increase even more
in the next few years. The trend towards implantation of
pacemakers in older age groups is also accompanied by an
increasing number of co-morbidities in those patients. A re-
cently published study by Kurtz et al. [4] has shown that the
Figure 1
Histological specimen of the heart muscle obtained in a pig with
implanted conventional pacemaker lead after imaging with a high
power RF MRI scan. Tissue damage due to heating around the
lead tip is visible (arrow). Note: The location of the lead tip is
highlighted by asterisks.
A
B
Figure 2
A Axial post-contrast MR image in patient with an MRI SureScan
pacemaker.
All anatomical details including left atrial appendage, left pulmonary
vein and the main stem of the left coronary artery (arrowhead) are
visualised well. The lead of the pacemaker causes only a small
artifact (arrow).
B MR image in short-axis view in a patient with a SureScan
pacemaker. The proximal portion of the right ventricle is well
visualised. The pacemaker lead creates an artifact at the posterior
aspect of the tricuspid valve annulus (arrow). RCA = right coronary
artery; PA = pulmonary artery; TVP = tricuspid-valve plane; LV = left
ventricle.
(images courtesy of Prof. J. Schwitter, CHUV, Lausanne/CH).
co-morbidity index in Medicare patients with newly im-
planted pacemakers increased in the period 1993–2006.
Considering the prevalence of frequently occurring dis-
eases in the older age group, it is evident that diseases
affecting the neurological, cardiovascular and musculo-
skeletal system are particularly frequent. Precisely in this
disease spectrum MRI is a very powerful method not only
for diagnosis but also for monitoring of disease. Although
there are imaging alternatives for a wide spectrum of dis-
eases, there are some diseases where MRI is the only ima-
ging method to establish the diagnosis. Reflecting all these
issues, it has been estimated that in 50–75% of all pace-
maker patients an MRI examination is indicated at least
once in the lifetime of their device [5]. Since there is an in-
creasing need for MR imaging in such patients, MRI-com-
patible pacemakers are a desideratum [1].
MRI and conventional pacemakers
In this paper we use the term “conventional pacemakers”
when discussing pacemaker-related issues concerning
devices which are not specifically designed for use with
MRI scanning. Conventional pacemakers encompass
nearly all pacemakers which are currently on the market,
with the exception of the newly available MR compatible
pacing systems with the trade names MRI SureScan
(Medtronic International, Tolochenaz, Switzerland) and
ProMRI (Biotronik GmbH & Co., Berlin, Germany).
MRI in patients with conventional cardiac pacemakers may
be hazardous due to the possible interaction of the device
with the different electromagnetic field used for MRI
[6–8]. It is important to underline that both the device itself
and the leads may interact with the different electromagnet-
ic fields used in MRI. MRI uses three different electromag-
netic fields to produce images: the main magnetic field; the
time-varying magnetic gradient fields, and the pulsed radi-
ofrequency (RF) field. The main magnetic field is used to
align protons and is always on. Currently, MR imaging is
performed at magnetic field strengths between 0.5 and 3.0
Tesla (T), whereas most MR scanners work at 1.5 T. The
time-varying magnetic gradient fields are used for spatial
localisation and change their strength along different ori-
entations. The pulsed RF-field is generated by the body coil
or send/receive coils and is used to change the energy state
of the protons as well as elicit MRI signals from tissue.
Pacemakers can interact with all of the three types of elec-
tromagnetic field used during MRI. The theoretical inter-
actions between conventional pacemakers and the electro-
magnetic fields affecting the device and the leads are listed
in table 1.
The most important risk posed by MR imaging in patients
with pacemakers is a transient or permanent influence or
definite damage to the electric components of the pace-
maker device (i.e., activation of the reed-switch, pace-
maker resets of reprogramming). This interaction may lead
to asynchronous or unpredictable pacing, which may result
in tachycardia or asystole [9]. Also, animal testing has
demonstrated that the temperature at the lead tip increased
up to 20 °C during MRI scanning of the heart, thus possibly
resulting in tissue damage [10] (fig. 1). The risk of pace-
maker displacement by a possible interaction with the static
magnetic field is considered to be of minor importance.
Another disadvantage of conventional pacemakers is the
fact that the device and the leads produce metallic artifacts
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which may hamper imaging interpretation at the level of
the heart and the mediastinum. First experience with MRI
SureScan devices did indicate that the artifacts induced by
the leads and the device itself may not limit the MR scan’s
diagnostic value (fig. 2).
The potentially hazardous complications for patients with
a conventional pacemaker in whom MRI were accidentally
performed are underlined by the reported lethal conse-
quences in these patients. In Germany alone there have
been six fatalities relating to MR examinations in pace-
maker patients [11]. In three of these cases there was sug-
gestive evidence that death may have occurred due to in-
duced ventricular fibrillation [11]. It may be assumed that
the complication rate in patients with pacemakers accident-
ally undergoing MR imaging is higher than is reflected by
the number of cases published in the literature.
The potentially lethal outcome from the interaction of MR-
generated electromagnetic interference on pacemakers
provides the medical basis for the widely held view that
MRI is absolutely contraindicated in patients with cardiac
pacemakers.
Several reports in the literature have questioned this strict
viewpoint with regard to the use of MRI in pacemaker pa-
tients. In these studies more or less large series of pace-
maker patients are described who have safely undergone
MR scanning [8, 12–16]. The common feature of these
studies is that they all were performed under dedicated
safety precautions (such as patient selection, monitoring,
reanimation preparedness, prior and subsequent examina-
tions), and that imaging should be performed in body areas
more distant from the chest, such as the brain and knee.
In addition, special pacemaker program settings (such as
the OFF mode; i.e., sensing (monitoring)-only mode (0A0,
0V0, 0D0)) are recommended in order to avoid arrhythmias
when MR imaging is performed [15].
It is against the background of these controversial data that
the safety guidelines of professional societies of medic-
al physicists, cardiologists and radiologists regarding MR
safety of conventional pacemakers have to be seen. Al-
though the recommendations of the ACR Blue Ribbon pan-
el on MR Safety, the European Heart Rhythm Association
and Working Group on Cardiovascular Magnetic Reson-
ance of the European Society of Cardiology (EuroCMR),
the American College of Cardiology Foundation, the North
American Society for Cardiac Imaging differ slightly from
each other, it is commonly agreed that MRI in pacemakers
is not clinical routine and MRI should only be performed
under dedicated safety precautions and by experienced per-
sonnel from medical physics, cardiology and radiology
[17–19]. It is evident that the indication to perform MRI in
these patients must be very strict, and there should be con-
sensus between the referring clinician and the radiologist
on the clinical need for the exam, meaning that no other
imaging method is available to answer the relevant clinical
question.
Data on the management of patients with conventional
pacemakers who are referred for MRI in clinical practice
are scarce in the literature. In a 2001 survey from the
Cleveland Clinic [20] academic cardiologists and radiolo-
gists were asked whether they would scan a pacemaker
patient. Responses from radiologists suggested that 97%
would not do so, whereas 34% of the cardiologists said
they would do so under certain circumstances.
Swiss survey on the use of MR in pacemaker patients
We performed a survey designed to explore the current
practice and knowledge of radiologists with regard to MRI
in patients with a conventional pacemaker.
The purpose of this survey of radiologists in Switzerland
was twofold: first, to provide data on the use of MR ima-
ging in pacemaker patients, and second, to determine the
potential use of MRI conditional pacemakers.
Material and methods
Based on the records of a dedicated company acting in
health care consulting (IMS Health GmbH, Hergiswil,
Switzerland) a total of 576 board-certified radiologists
working in public and private hospitals and in private prac-
tice in all parts of Switzerland were contacted in writing.
All radiologists were asked to complete a fully-structured
online questionnaire available in German and French. All
participants received a personal password along with the
access information. Only one questionnaire could be com-
pleted per password. In addition to the personal details
(name, position, institution), the 25-question questionnaire
gathered institution-specific information, such as the fre-
quency and handling of cases in which patients were re-
ferred for MR examination despite their having pace-
makers. The questions also addressed the potential use of
MR conditional pacemakers and the practical procedure or
administration of MR examinations in patients with MR
conditional pacemakers. The survey took place within a
period of six weeks from March to April 2009, months
before the first MRI conditional pacemaker was commer-
cially available.
Table 1: Potential interactions of MRI on a pacemaker device (from [9]).
Pacemaker Lead
Main magnetic field Magnetic forces1 Magnetic forces1
Magnetic torque1 Magnetic torque1
Interaction with the reed-switch2
Destruction of the device in case of high voltage charging2
Gradient field Inhibition/Fast pacing2 Stimulation of the heart2
Pacemaker resetting2
Vibrations1
RF field Destruction of device circuits2 Heating effects at the tip of the leads2
Pacemaker reprogramming2
Pacemaker resetting2 Stimulation of the heart2
Inhibition/Fast pacing2
1 Interactions of theoretical concern but without clinical relevance in humans.
2 Reported interactions of conventional pacemakers during MRI in humans.
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Results
Demographics of participants and radiological
equipment
A total of 70 Swiss radiologists participated in the survey
(total participation rate of 12%). All participants fully com-
pleted the questionnaire. Participants were from 56 radi-
ological institutions (radiological institutes in public hos-
pitals, 37 (53%); radiological institutes in private hospitals,
15 (21%) and private practice not in a hospital setting, 18
(26%). Fifty-five of 56 institutions (98%) of which a radi-
ologist took part in the survey were equipped with at least
one MR scanner. 83% of the participating radiology insti-
tutes located either in private or public hospitals had per-
manent access to a cardiology department. Among the ra-
diologists working in private practice, 61% had no access
to a permanently employed cardiologist.
The distribution of MR scanners according to magnetic
field strength was as follows: 76 1.5 Tesla (T) MR scan-
ners, 37 3.0 T MR scanners, and 17 MR scanners with
a magnetic field strength below 1.0 T. The mean number
of MR examinations performed per centre was 5516 (SD
= 3581). The majority of the radiologists (67%) described
their interest in the topic of MRI and pacemakers as
“great”, 29% as “moderate”, and 4% as “little” or “no in-
terest”.
Current practice in pacemaker patients with regard to
MR imaging
A patient with an implanted pacemaker is considered an
absolute contraindication for MR examination by 93% of
the radiologists. Approximately 7% of the radiologists in-
terviewed reported that the presence of a pacemaker was
considered a relative contraindication in their institution. In
2008 in each institution approximately 30 pacemaker pa-
tients on average were referred for MR examination. In
2008, in only one patient with a conventional MR pace-
maker was an MR scan performed among all institutions
in Switzerland. An alternative imaging method was used in
all other patients with conventional pacemakers who were
initially referred for possible MR scanning. Approximately
58% of responders consulted the referring physician where
Figure 3
Prerequisites and patient workflow of a patient with a conditional
cardiac pacemaker (PM) who needs an MR scan.
the referral was of a patient with a pacemaker. Only a
minority subsequently performed the requested scan, usu-
ally after consultation and under supervision, and/or with
prior or subsequent examination by a cardiologist.
Radiologists were asked to estimate the proportion of pa-
tients who, because of the pacemaker contraindication, are
probably not referred for an MR examination at the radi-
ological institution at all, and examined instead by other
imaging methods. The proportion of MR examinations not
carried out at the survey participants’ workplaces (because
refused) was estimated at a mean of 1.9% (SD 1.8%) of all
MR examinations.
This survey underlines the careful approach of radiologists
working in Switzerland when patients with conventional
pacemakers are referred for MRI. MRI in patients with
conventional pacemakers is currently considered an ab-
solute contraindication for the majority of patients, and
is only performed when there is no alternative imaging
method and under strict safety conditions. If an MR ex-
amination in a patient with a conventional pacemaker is
performed, the procedure is done under strict safety pre-
cautions and in close cooperation with a cardiologist and
a medical physicist. We acknowledge the following limit-
ations of the study: first, with the exception of one single
institution, all radiologists who took part in the survey
worked in institutions which were equipped with at least
one MR scanner. Second, the response rate of the radiolo-
gists initially contacted was relatively low.
To summarise, the survey has demonstrated that clinical
practice does not follow the recommendations of the pro-
fessional societies which consider patients with conven-
tional pacemakers a relative contraindication for MR ex-
aminations. The clinical practice in Switzerland is stricter
in this patient group.
MR conditional pacemakers
An MR conditional pacemaker is a specially designed
device for safe use in the MR environment. MR conditional
pacemakers are dedicated pacing systems designed to
avoid potential interactions with the electromagnetic fields
of MR imaging, and to avoid complications of conven-
tional pacemakers including arrhythmias, inhibition of the
pacing output, triggered stimulations and radiofrequency
heating of the pacing leads with potential thermal damage
to the electrode/tissue interface. Technically the MR com-
patibility of these conditional pacemakers is achieved by
minimising the energy discharged at electrodes and by en-
suring reliable operation while MRI is active. Special
design of the leads is necessary to reduce lead tip heating
from RF. However, since MR is a rapidly evolving imaging
method and as long as a pacing system contains wires, the
term “MR safe” will never be applied, and in particular also
considering the legal aspects. Therefore, any MR compat-
ible cardiac pacemaker will be called MR conditional. The
term “conditional” means that the device can undergo an
MR examination under conditions provided by the pace-
maker manufacturer, such as maximum specific absorption
rate (SAR) levels, allowed field strength, excluded body re-
gions etc.
In the above-mentioned survey the radiologists were also
asked for their opinion on MR conditional pacemakers. The
usefulness of MR conditional pacemakers was considered
by survey responders to be “great”. On a scale of 0 (“not
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useful”) to 6 (“very useful”), the average score was 4.97.
Their usefulness in patients with cerebral diseases or injur-
ies and spinal cord diseases or injuries was rated highest.
Clinical experience with MR conditional pacemakers
The first MR conditional pacemaker system has been on
the market since 2010 (the Enrythm® MRI SureScan™
pacemaker). The Enrythm MRI SureScan pacing system
has been successfully tested pre-clinically and clinically
in 1.5 T MR scanners [21–22]. In two trials MR scans of
the brain and lumbar spine were successfully performed
without complications in patients with MR conditional
pacemakers [21–22]. Based on the positive results of the
aforementioned studies as well as on other unpublished
safety data, the MRI SureScan device was initially author-
ised for use in MR scanners with a magnetic field strength
of up to 1.5 T and in all body regions but with a restric-
tion on imaging of the chest. In the meantime the MRI
SureScan system has been extensively tested in computer
models and in vivo canine studies for the entire MR ima-
ging spectrum including MR imaging of the chest with
the heart (internal unpublished safety data of Medtronic).
Based on these additional safety data the MRI Surescan
pacemaker system received the CE mark of approval for
the full body scan indication (fig. 3). FDA approval will be
forthcoming in 2011. Another MR conditional pacemaker
system has recently been marketed (ProMRI pacing sys-
tem). Similar to the first generation of SureScan devices,
the ProMRI pacing system is restricted to scanning outside
the chest.
The common feature of all currently available MR condi-
tional pacemakers is that these devices should not undergo
MR imaging at any other magnetic field strengths than 1.5
T.
Clinical experience with MR compatible pacemakers is so
far limited. In a prospective trial Forleo et al. [23] com-
pared the safety and effectiveness of an MR conditional
pacemaker system with a conventional DDD implant. The
investigators reported no difference between the two
groups with regard to implantation or technical success
rates. The prerequisites and workflow of a patient with
an MR compatible pacemaker who needs an MR scan is
shown in figure 3. It is of practical importance that a special
programming modus (MRI mode) must be set on the MR
conditional pacemaker before the MR scanner. After scan-
ning this MRI mode must be turned off. Usually both the
setting and turning-off of the MRI mode are done by the
cardiologist.
Which patients are candidates for implantation of MR
conditional pacemakers?
With the introduction of MR conditional pacemakers the
discussion regarding the patients in whom the device
should be implanted is launched. Clearly at this time there
are not enough data available to conclude that MR con-
ditional pacemakers are equal to conventional pacemakers
with regard to technical success, functionality and long
term results. However, assuming that MR conditional pace-
makers and conventional pacemakers are equal with regard
to technical success, efficacy and outcome, selection of the
device should be evaluated carefully. At the present time,
patients who need a pacemaker and who have a pre-ex-
isting co-morbidity of an oncological, neurological, ortho-
paedic or cardiovascular disease should be proposed for
implantation of an MR conditional pacemaker system. Al-
ternatively, the patients should at least be considered for
implantation of MR compatible leads. Although this seems
to be a short term strategy, since almost all device manu-
facturers are announcing MR conditional pacemakers, it is
very likely that MR conditional pacemakers will become
standard of care in the near future.
Outlook
Currently available MR conditional pacing systems meet
an increasing demand for imaging in a growing number of
patients with pacemakers. New generations of MR pace-
makers with fewer restrictions and more automaticity can
be expected, resulting in faster and easier procedures. Fu-
ture research will also be directed to development of MR
compatible implantable cardioverter defibrillator (ICD)
devices. However, at the time of writing there is no ICD
product on the horizon which meets the demand for an MR
conditional ICD.
Future generations of MR compatible pacemakers will also
be approved for 3.0 T scanning, although at this time this is
not a real limitation since MR imaging at 1.5 T is adequate
for most imaging requirements.
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